Anesthesia With Propofol Sedation Reduces Locoregional Recurrence in Patients With Breast Cancer Receiving Total Mastectomy Compared With Non-Propofol Anesthesia

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Mar 21

PMID 35311108

Authors

Jiaqiang Zhang

Chia-Lun Chang

Chang-Yun Lu

Ho-Min Chen

Szu-Yuan Wu

Affiliations

Soon will be listed here.

Abstract

Purpose: We examined locoregional recurrence (LRR) in patients with breast invasive ductal carcinoma (IDC) receiving total mastectomy (TM) under propofol-based paravertebral block-regional anesthesia (PB-RA) versus sevoflurane-based inhalational general anesthesia (INHA-GA) without propofol. All-cause death and distant metastasis were secondary endpoints.

Patients And Methods: Patients with breast IDC receiving TM were recruited through propensity score matching and categorized into INHA-GA with sevoflurane and PB-RA with propofol groups. Cox regression analysis was performed to calculate hazard ratios (HRs) and 95% confidence intervals (CIs).

Results: In the multivariate Cox regression analysis, the adjusted HR (aHR; 95% CI) of LRR for the PB-RA with propofol group was 0.52 (0.28-0.96) compared with the INHA-GA with sevoflurane group. The aHRs of LRR for differentiation grade II, grade III, the American Joint Committee on Cancer clinical stage II, stage III, pathological tumor (pT) stage 2, pT stage 3-4, pathological nodal (pN) stage 1, and pN stage 2-3 were 1.16 (1.04-2.08), 1.28 (1.07-2.12), 3.71 (1.82-7.59), 4.67 (1.65-13.18), 1.09 (1.02-1.21), 1.17 (1.03-2.16), 1.10 (1.03-1.33), and 1.22 (1.06-2.41), respectively, compared with differentiation grade I, clinical stage I, pT1, and pN0. The aHR of LRR for adjuvant RT was 0.88 (0.64-0.94) compared with that for no adjuvant RT.

Conclusion: PB-RA with propofol might be beneficial for reducing LRR in women with breast IDC receiving TM compared with INHA-GA without propofol.

Citing Articles

Survival benefits of propofol-based versus inhalational anesthesia in non-metastatic breast cancer patients: a comprehensive meta-analysis.

Zhang Y, Yu P, Bian L, Huang W, Li N, Ye F Sci Rep. 2024; 14(1):16354.

PMID: 39014134 PMC: 11252424. DOI: 10.1038/s41598-024-67291-4.

An intravenous anesthetic drug-propofol, influences the biological characteristics of malignant tumors and reshapes the tumor microenvironment: A narrative literature review.

Zhou X, Shao Y, Li S, Zhang S, Ding C, Zhuang L Front Pharmacol. 2022; 13:1057571.

PMID: 36506511 PMC: 9732110. DOI: 10.3389/fphar.2022.1057571.

References

Zhang J, Lu C, Chen C, Chen H, Wu S . Effect of pathologic stages on postmastectomy radiation therapy in breast cancer receiving neoadjuvant chemotherapy and total mastectomy: A Cancer Database Analysis. Breast. 2020; 54:70-78. PMC: 7501458. DOI: 10.1016/j.breast.2020.08.017. View

Recht A, Come S, Henderson I, Gelman R, Silver B, Hayes D . The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med. 1996; 334(21):1356-61. DOI: 10.1056/NEJM199605233342102. View

West D, Satariano W, Ragland D, Hiatt R . Comorbidity and breast cancer survival: a comparison between black and white women. Ann Epidemiol. 1996; 6(5):413-9. DOI: 10.1016/s1047-2797(96)00096-8. View

Austin P . Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2010; 10(2):150-61. PMC: 3120982. DOI: 10.1002/pst.433. View

Yap A, Lopez-Olivo M, Dubowitz J, Hiller J, Riedel B . Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia. Can J Anaesth. 2019; 66(5):546-561. DOI: 10.1007/s12630-019-01330-x. View

Souron V, Vincent S, Delaunay L, Laurent D, Bonner F, Francis B . Sedation with target-controlled propofol infusion during shoulder surgery under interscalene brachial plexus block in the sitting position: report of a series of 140 patients. Eur J Anaesthesiol. 2005; 22(11):853-7. DOI: 10.1017/S0265021505001444. View

Zhang J, Lu C, Qin L, Chen H, Wu S . Breast-conserving surgery with or without irradiation in women with invasive ductal carcinoma of the breast receiving preoperative systemic therapy: A cohort study. Breast. 2020; 54:139-147. PMC: 7559874. DOI: 10.1016/j.breast.2020.09.010. View

Bonadonna G, Zambetti M, Valagussa P . Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results. JAMA. 1995; 273(7):542-7. View

Hong B, Lee S, Kim Y, Lee M, Youn A, Rhim H . Anesthetics and long-term survival after cancer surgery-total intravenous versus volatile anesthesia: a retrospective study. BMC Anesthesiol. 2019; 19(1):233. PMC: 6921541. DOI: 10.1186/s12871-019-0914-4. View

10.

Zhang J, Lu C, Qin L, Chen H, Wu S . Outcome of post-mastectomy radiotherapy after primary systemic treatment in patients with different clinical tumor and nodal stages of breast cancer: a cohort study. Am J Cancer Res. 2020; 10(7):2185-2198. PMC: 7407353. View

11.

Dogan Baki E, Aldemir M, Kokulu S, Koca H, Ela Y, Sivaci R . Comparison of the effects of desflurane and propofol anesthesia on the inflammatory response and s100β protein during coronary artery bypass grafting. Inflammation. 2013; 36(6):1327-33. DOI: 10.1007/s10753-013-9671-6. View

12.

Huang H, Benzonana L, Zhao H, Watts H, Perry N, Bevan C . Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination. Br J Cancer. 2014; 111(7):1338-49. PMC: 4183852. DOI: 10.1038/bjc.2014.426. View

13.

Fu J, Wu L, Jiang M, Li D, Jiang T, Hong Z . Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer. PLoS One. 2016; 11(10):e0164921. PMC: 5070827. DOI: 10.1371/journal.pone.0164921. View

14.

Ecimovic P, McHugh B, Murray D, Doran P, Buggy D . Effects of sevoflurane on breast cancer cell function in vitro. Anticancer Res. 2013; 33(10):4255-60. View

15.

Enlund M, Berglund A, Andreasson K, Cicek C, Enlund A, Bergkvist L . The choice of anaesthetic--sevoflurane or propofol--and outcome from cancer surgery: a retrospective analysis. Ups J Med Sci. 2014; 119(3):251-61. PMC: 4116765. DOI: 10.3109/03009734.2014.922649. View

16.

Pei L, Zhou Y, Tan G, Mao F, Yang D, Guan J . Ultrasound-Assisted Thoracic Paravertebral Block Reduces Intraoperative Opioid Requirement and Improves Analgesia after Breast Cancer Surgery: A Randomized, Controlled, Single-Center Trial. PLoS One. 2015; 10(11):e0142249. PMC: 4654480. DOI: 10.1371/journal.pone.0142249. View

17.

Zhang J, Lu C, Chen H, Wu S . Neoadjuvant Chemotherapy or Endocrine Therapy for Invasive Ductal Carcinoma of the Breast With High Hormone Receptor Positivity and Human Epidermal Growth Factor Receptor 2 Negativity. JAMA Netw Open. 2021; 4(3):e211785. PMC: 7955271. DOI: 10.1001/jamanetworkopen.2021.1785. View

18.

Jiang S, Liu Y, Huang L, Zhang F, Kang R . Effects of propofol on cancer development and chemotherapy: Potential mechanisms. Eur J Pharmacol. 2018; 831:46-51. DOI: 10.1016/j.ejphar.2018.04.009. View

19.

Weng M, Chen W, Hou W, Li L, Ding M, Miao C . The effect of neuraxial anesthesia on cancer recurrence and survival after cancer surgery: an updated meta-analysis. Oncotarget. 2016; 7(12):15262-73. PMC: 4924785. DOI: 10.18632/oncotarget.7683. View

20.

Austin P . The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med. 2013; 33(7):1242-58. PMC: 4285179. DOI: 10.1002/sim.5984. View